Position
Creative Planning in Biomarin Pharmaceutical Inc
Back to the book · All holders of BMRN
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$199.5K$59.43 → $56.49
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 67.8K | $4.03M | — | — | — | 0.0% |
| Q1 2026 | 113.1K | $6.39M | $56.49 | −$199.5K | $2.56M | 0.0% |